When Penny Stocks Can Become Compelling: A Long-Term Buy With CYDY
Introduction CytoDyn Inc. (CYDY) is a clinical-stage biotechnology company developing leronlimab (PRO 140), a humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is being explored in multiple therapeutic areas, including HIV, immunology ( …